Today: 5 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

PayPal stock slides again as downgrades pile up after CEO shake-up

PayPal stock slides again as downgrades pile up after CEO shake-up

PayPal shares fell 3.3% to $39.67 Thursday after the company named HP’s Enrique Lores as CEO and warned of a weaker 2026 outlook. CFO Jamie Miller cited pressure on retail merchants and sluggish branded checkout growth. Multiple analysts downgraded the stock, citing competition from Apple Pay and Google Pay. PayPal declared a $0.14 dividend and forecast a mid-single-digit drop in Q1 adjusted earnings.
5 February 2026
·
Estée Lauder stock sinks 21% as 2026 outlook, tariffs rattle investors

Estée Lauder stock sinks 21% as 2026 outlook, tariffs rattle investors

Estée Lauder shares fell 21% Thursday to $94.45 after a full-year forecast pointed to slower growth in its main market. The company reported fiscal Q2 net sales of $4.229 billion and raised its 2026 outlook, but warned of higher tariffs and shrinking Q3 margins. Estée Lauder plans to cut up to 7,000 jobs and pay a 35-cent dividend March 16. Coty and e.l.f. Beauty shares also dropped.
5 February 2026
·
Shopify stock drops again: AI disruption jitters and Feb. 11 earnings loom for SHOP

Shopify stock drops again: AI disruption jitters and Feb. 11 earnings loom for SHOP

Shopify shares fell 2.1% to $111.59 Thursday, swinging between $108.90 and $115.71 as software stocks faced heavy selling. The S&P 500 software and services index dropped about 3%, with sector losses nearing $1 trillion since Jan. 28. Investors are watching Shopify’s Feb. 11 earnings for signs of AI’s impact on margins. New unemployment claims rose and job openings hit a five-year low.
5 February 2026
···
P&G stock climbs while Wall Street slides — what’s behind PG’s move and what comes next

P&G stock climbs while Wall Street slides — what’s behind PG’s move and what comes next

Procter & Gamble shares climbed 1.3% to $158.89 Thursday afternoon, bucking a broader market decline driven by tech sector weakness. SEC filings showed insider sales by executives Ma. Fatima Francisco and a proposed sale by Gary A. Coombe. Consumer staples led S&P 500 sector gains, while tech stocks fell on AI spending concerns. Trading volume reached 9.1 million shares.
5 February 2026
·
Adobe stock slides again as AI worries hit software; what ADBE investors watch next

Adobe stock slides again as AI worries hit software; what ADBE investors watch next

Adobe shares fell 3.5% to $270.01 Thursday as software stocks slid, following a downgrade by Piper Sandler and ongoing concerns over AI’s impact on the sector. The S&P 500 software and services index dropped 2.8%, erasing over $950 billion in value since Jan. 28. Investors are watching Adobe’s March 12 earnings call for signs of demand and AI returns.
5 February 2026
··
Coca-Cola stock price rises as Jefferies lifts target ahead of Feb. 10 earnings

Coca-Cola stock price rises as Jefferies lifts target ahead of Feb. 10 earnings

Coca-Cola shares rose 1.7% to $78.65 Thursday, bucking a weaker U.S. market after Jefferies raised its price target to $88 ahead of next week’s earnings. CEO-elect Henrique Braun will take over March 31 as James Quincey becomes executive chairman. Quincey sold 337,824 shares for about $26 million on Feb. 3 under a prearranged plan. Coca-Cola reports fourth-quarter and full-year results Feb. 10.
5 February 2026
····
Credo Technology stock rebounds today as AI-chip jitters ease; what’s next for CRDO

Credo Technology stock rebounds today as AI-chip jitters ease; what’s next for CRDO

Credo Technology shares rose about 2% to $98.96 Thursday afternoon, rebounding after recent losses. A Bank of America note challenged the AI-chip selloff, citing sector bottlenecks. Insider-sale filings and a March earnings report kept traders cautious. Roughly 5.8 million shares traded as Credo’s market cap neared $32.5 billion.
5 February 2026
····
Vertiv (VRT) stock slides as AI jitters hit data-center plays ahead of earnings

Vertiv (VRT) stock slides as AI jitters hit data-center plays ahead of earnings

Vertiv shares fell 1.8% to $179.36 Thursday, hitting a low of $172.59 as investors retreated from costly AI-linked stocks amid concerns over capital spending. The company reports earnings Feb. 11, with investors watching for signs of demand in data-center cooling. Peers like Eaton and Johnson Controls also saw volatile trading this week.
5 February 2026
·····
Ondas (ONDS) stock slides again after J Capital report; Rotron deal and Singapore Airshow in focus

Ondas (ONDS) stock slides again after J Capital report; Rotron deal and Singapore Airshow in focus

Ondas shares fell about 9% to $8.77 in afternoon trading Thursday, extending losses after a critical report from J Capital Research. The drop followed recent announcements of an Asia-Pacific defense contract and a deal to acquire UK-based Rotron Aero. Trading volume reached roughly 76 million shares. The J Capital note accused Ondas of risky acquisitions and heavy share dilution.
5 February 2026
Chevron stock slips as oil drops ahead of U.S.-Iran talks and Chevron reshuffles top jobs

Chevron stock slips as oil drops ahead of U.S.-Iran talks and Chevron reshuffles top jobs

Chevron shares fell 1.2% to $179.12 as oil prices dropped and traders eyed upcoming U.S.-Iran talks. The company announced senior leadership changes, with several executives retiring and new appointments set for March and April. Chevron also signed exploration agreements in Syria and Qatar, and reaffirmed its commitment to the Yoyo-Yolanda gas project in Africa.
5 February 2026
···
Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval

Merck stock rises 2% in New York as MRK traders size up outlook and a fresh RSV approval

Merck shares rose about 2% to $120.72 Thursday after forecasting 2026 sales and profits below Wall Street estimates, citing patent expiries on older drugs. The company reported Q4 global sales of $16.4 billion and non-GAAP EPS of $2.04, and expects 2026 sales of $65.5–$67.0 billion. Health Canada approved ENFLONSIA for RSV prevention in infants. FDA review of WINREVAIR is set for September 21, 2026.
5 February 2026
··
JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

Johnson & Johnson shares rose 1.3% to $237.59 after the company asked the U.S. Supreme Court to review a shareholder lawsuit over talc safety claims. The petition challenges a Third Circuit ruling on class certification standards. The case is separate from ongoing talc injury suits. Investors are also watching for new data on J&J’s atrial fibrillation devices at a cardiology event this week.
5 February 2026
··
1 … 96 97 98 99 100 … 688
Go toTop